PDC-41 series (PDC)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePDC-41 series (PDC)
Drug Alias NameTHG-113.31 (PDC Biotech)PDC-31 (PDC)THG-113 (PDC Biotech)PDC-411
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionProstanoid FP receptor antagonists
TargetsProstanoid FP receptor
Therapy Area/IndicationsDysmenorrhea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheratechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPdc Biotech Gmbh
Active IndicationsN/A
Inactive IndicationsDysmenorrhea

Other Information

ATC CodeN/A
Related LinksN/A